Today’s biotech news roundup, in under 800 words
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Today, we talk lots about clinical trial inconsistencies: How Canada’s trial reporting is not up to snuff, and how companies perpetually want to spin results to make their experimental medicine look more favorable. We also talk about how the ARIA stemming from Alzheimer’s drugs isn’t taken seriously enough, and how state and local governments are suing insulin makers over drug prices.
Read Original Article: Today’s biotech news roundup, in under 800 words »
